4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol and Syndrome

4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol has been researched along with Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alves, AF; Bezerra Barros, GC; Ferreira, LAMP; Mozzini Monteiro, T; Paiva Ferreira, LKD; Pereira, RA; Piuvezam, MR	1

Other Studies

1 other study(ies) available for 4-methyl-1-(1-methylethyl)-3-cyclohexen-1-ol and Syndrome

Article	Year
4-Carvomenthenol ameliorates the murine combined allergic rhinitis and asthma syndrome by inhibiting IL-13 and mucus production via p38MAPK/NF-κB signaling pathway axis. International immunopharmacology, 2020, Volume: 88 Topics: Allergens; Animals; Anti-Allergic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Female; Interleukin-13; Lung; Menthol; Mice, Inbred BALB C; Mucus; NF-kappa B; Ovalbumin; p38 Mitogen-Activated Protein Kinases; Rhinitis, Allergic; Signal Transduction; Syndrome	2020

Article

Year

4-Carvomenthenol ameliorates the murine combined allergic rhinitis and asthma syndrome by inhibiting IL-13 and mucus production via p38MAPK/NF-κB signaling pathway axis.

International immunopharmacology, 2020, Volume: 88

Topics: Allergens; Animals; Anti-Allergic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Female; Interleukin-13; Lung; Menthol; Mice, Inbred BALB C; Mucus; NF-kappa B; Ovalbumin; p38 Mitogen-Activated Protein Kinases; Rhinitis, Allergic; Signal Transduction; Syndrome

2020